Journals / The Journal of Breast Health / 2015 / Cilt: 11 - Sayı: 3

Meme Kanserli Hastalarda Ameliyat Sonrası Hastanede Kalış Süresini Etkileyen Faktörler

Factors Affecting the Postsurgical Length of Hospital Stay in Patients with Breast Cancer

Pages
128–131
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, drains should be avoided unless required and, if used, they should be removed as early as possible for shortening LOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Breast cancer is the most common malignancy and the most common cause of mortality in women worldwide.
📊
Key Findings & Data:Because LOS is key in determining hospital usage, the decrease in the use of hospital facilities may have implications on healthcare planning.
💡
Conclusion & Impact:In addition, drains should be avoided unless required and, if used, they should be removed as early as possible for shortening LOS.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Breast cancer is the most common malignancy and the most common cause of mortality in women worldwide. In addition to the increasing incidence of breast cancer, the length of hospital stay (LOS) after breast cancer surgery has been decreasing. Because LOS is key in determining hospital usage, the decrease in the use of hospital facilities may have implications on healthcare planning. The purpose of this study was to evaluate the factors affecting postoperative LOS in patients with breast cancer. Materials and Methods: Seventy-six in patients with breast cancer, who had been treated between July 2013 and December 2014 in the General Surgery Clinic of Dicle University, were included in the study. The demographic characteristics of the patients, treatment methods, histopathological features of the tumor, concomitant diseases, whether they underwent neoadjuvant chemotherapy or not, and the length of drain remaining time were retrospectively recorded. Results: There was a correlation between drain remaining time, totally removed lymph node, the number of metastatic lymph node, and LOS. LOS of patients treated with neoadjuvant chemotherapy was longer. The patients who underwent breast-conserving surgery had a shorter LOS. Linear regression analysis revealed that the drain remaining time and the number of metastatic lymph nodes were independent risk factors for LOS. Conclusion: Consideration should be given to cancer screening to diagnose the patients before lymph node metastasis occurs. In addition, drains should be avoided unless required and, if used, they should be removed as early as possible for shortening LOS.

Özet

Amaç: Meme kanseri en sık görülen malignite ve dünya çapında kadınlarda en sık ölüm nedenidir. Meme kanseri sıklığı giderek artmasına rağmen, meme kanseri cerrahisi sonrası hastanede kalış süresinde düşüş olmuştur. Hastane kullanımını belirlemede kalış süresi önemli olduğundan, hastane kaynaklarının kullanımında azalma sağlık planlaması için etkili olabilir. Bu çalışmanın amacı, meme kanserli hastalarda ameliyat sonrası hastanede kalış süresini etkileyen faktörleri değerlendirmektir. Yöntem ve Gereçler: Dicle Üniversitesi Genel Cerrahi Kliniğinde Temmuz 2013 ile Aralık 2014 arasında tedavi görmüş meme kanserli, 76 yatan hasta çalışmaya dahil edildi. Hastaların demografik özellikleri, tedavi yöntemleri, tümörün histopatolojik özellikleri, eşlik eden hastalıklar, neoadjuvan kemoterapi alıp almadıkları ve dren kalış süresi retrospektif kaydedildi. Bulgular: Dren kalış süresi, metastatik ve çıkarılan total lenf nodu sayısı ile hastanede kalış süresi arasında korelasyon vardı. Neoadjuvan kemoterapi alan hastalarda hastanede yatış süresi daha uzundu. Meme koruyucu cerrahi yapılan hastalarda ise hastanede kalış süresi mastektomi yapılanlara göre daha kısa idi. Lineer regresyon analizi değerlendirmesinde dren kalış süresi ve metastatik lenf nodu sayısı hastanede yatış süresi üzerinde etkili bağımsız prediktif faktörler olarak saptandı. Sonuç: Lenf nodu metastazı ortaya çıkmadan teşhis sağlayan kanser taramasına önem verilmelidir. Hastanede kalış süresini azaltmak için dren sadece gerekli durumlarda kullanılmalı ve kullanıldığı takdirde mümkün olduğunca erken çekilmelidir.

🔖

Cite This Article

GÜMÜŞ, M., SATICI, Ö., ÜLGER, B. V., OĞUZ, A., TAŞKESEN, F., GİRGİN, S. (2015). Meme Kanserli Hastalarda Ameliyat Sonrası Hastanede Kalış Süresini Etkileyen Faktörler. The Journal of Breast Health, Cilt: 11 - Sayı: 3, 128–131. https://ajindex.com/articles/362678

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001
  2. (PMID: 11905707) [CrossRef] 2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005
  3. (PMID: 15761078) [CrossRef] 3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007
  4. (PMID:17287242) [CrossRef] 4. de Kok M, Frotscher CN, van der Weijden T, Kessels AG, Dirksen CD, van de Velde CJ, Roukema JA, Bell AV, van der Ent FW, von Meyenfeldt MF.Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study.BMC Cancer 2007
  5. (PMID: 17605796) [CrossRef] 5. Will BP, Berthelot JM, Le Petit C, Tomiak EM, Verma S, Evans WK. Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer 2000
  6. (PMID: 10762744) [CrossRef] 6. Will BP, Berthelot JM, Nobrega KM, Flanagan W, Evans WK. Canada’s Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions. Eur J Cancer 2001
  7. (PMID: 11549434) [CrossRef] 7. Marla S, McMillan DC, Stallard S. Factors influencing postoperative length of hospital stay after breast cancer surgery. Breast 2013
  8. (PMID: 22841480) [CrossRef] 8. Dooley WC. Ambulatory mastectomy. Am J Surg 2002
  9. (PMID: 12488162) [CrossRef] 9. Margolese RG, Lasry JC. Ambulatory surgery for breast cancer patients. Ann SurgOncol 2000
  10. (PMID: 10791847) [CrossRef] 10. Warren JL, Riley GF, Potosky AL, Klabunde CN, Richter E, Ballard-Barbash R. Trends and outcomes of outpatient mastectomy in elderly women. J Natl Cancer Inst 1998
  11. (PMID: 9625171) [CrossRef] 11. McManus SA, Topp DA, Hopkins C. Advantages of outpatient breast surgery. Am Surg 1994
  12. (PMID: 7992976) 12. Goodman AA, Mendez AL. Definitive surgery for breast cancer performed on an outpatient basis. Arch Surg 1993
  13. (PMID: 8215874) [CrossRef] 13. Vogel TR, Nackman GB, Crowley JG, Bueno MM, Banavage A, Odroniec K, Brevetti LS, Ciocca RG, Graham AM. Factors impacting functional health and resource utilization following abdominal aortic aneurysm repair by open and endovascular techniques. Ann Vasc Surg 2005
  14. (PMID: 16075344) [CrossRef] 14. BuSaba NY, Schaumberg DA. Predictors of prolonged length of stay after major electi